Weighted Average Number of Shares Outstanding, Diluted of EKSO BIONICS HOLDINGS, INC. from 30 Jun 2013 to 31 Dec 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
EKSO BIONICS HOLDINGS, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Jun 2013 to 31 Dec 2024.
  • EKSO BIONICS HOLDINGS, INC. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2024 was 20,161,000, a 45% increase year-over-year.
  • EKSO BIONICS HOLDINGS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 20,161,000, a 45% increase from 2023.
  • EKSO BIONICS HOLDINGS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 13,867,000, a 7% increase from 2022.
  • EKSO BIONICS HOLDINGS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 12,962,000, a 5.6% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

EKSO BIONICS HOLDINGS, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 20,161,000 +6,294,000 +45% 01 Oct 2024 31 Dec 2024 10-K 03 Mar 2025 2024 FY
Q3 2024 20,310,000 +6,237,000 +44% 01 Jul 2024 30 Sep 2024 10-Q 28 Oct 2024 2024 Q3
Q2 2024 18,224,000 +4,587,000 +34% 01 Apr 2024 30 Jun 2024 10-Q 29 Jul 2024 2024 Q2
Q1 2024 17,419,000 +4,123,000 +31% 01 Jan 2024 31 Mar 2024 10-Q 29 Apr 2024 2024 Q1
Q4 2023 13,867,000 +905,000 +7% 01 Oct 2023 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 14,073,000 +1,002,000 +7.7% 01 Jul 2023 30 Sep 2023 10-Q 28 Oct 2024 2024 Q3
Q2 2023 13,637,000 +753,000 +5.8% 01 Apr 2023 30 Jun 2023 10-Q 29 Jul 2024 2024 Q2
Q1 2023 13,296,000 +568,000 +4.5% 01 Jan 2023 31 Mar 2023 10-Q 29 Apr 2024 2024 Q1
Q4 2022 12,962,000 +693,000 +5.6% 01 Oct 2022 31 Dec 2022 10-K 04 Mar 2024 2023 FY
Q3 2022 13,071,000 +361,000 +2.8% 01 Jul 2022 30 Sep 2022 10-Q 26 Oct 2023 2023 Q3
Q2 2022 12,884,000 +147,000 +1.2% 01 Apr 2022 30 Jun 2022 10-Q 27 Jul 2023 2023 Q2
Q1 2022 12,728,000 +1,976,000 +18% 01 Jan 2022 31 Mar 2022 10-Q 27 Apr 2023 2023 Q1
Q4 2021 12,269,000 01 Oct 2021 31 Dec 2021 10-K 28 Mar 2023 2022 FY
Q3 2021 12,710,000 +4,331,000 +52% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 12,737,000 +6,476,000 +103% 01 Apr 2021 30 Jun 2021 10-Q 28 Jul 2022 2022 Q2
Q1 2021 10,752,000 01 Jan 2021 31 Mar 2021 10-Q 28 Apr 2022 2021 Q1
Q3 2020 8,379,000 +3,382,000 +68% 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021 2021 Q3
Q2 2020 6,261,000 01 Apr 2020 30 Jun 2020 10-Q 29 Jul 2021 2021 Q2
Q3 2019 4,997,000 -56,384,000 -92% 01 Jul 2019 30 Sep 2019 10-Q 29 Oct 2020 2020 Q3
Q3 2018 61,381,000 +26,661,000 +77% 01 Jul 2018 30 Sep 2018 10-Q 30 Oct 2019 2019 Q3
Q1 2018 60,146,000 +38,247,000 +175% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2018 2018 Q1
Q3 2017 34,720,000 +15,715,000 +83% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q1 2017 21,899,000 +6,511,000 +42% 01 Jan 2017 31 Mar 2017 10-Q 07 May 2018 2018 Q1
Q3 2016 19,005,000 +4,399,000 +30% 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2017 2017 Q3
Q1 2016 15,388,000 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q3 2015 14,606,000 -68,730,371 -82% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2016 Q3
Q2 2015 102,094,158 +7,321,747 +7.7% 01 Apr 2015 30 Jun 2015 10-Q 12 Aug 2015 2015 Q2
Q3 2014 83,336,371 +62,251,088 +295% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2015 Q3
Q2 2014 94,772,411 +73,691,997 +350% 01 Apr 2014 30 Jun 2014 10-Q 12 Aug 2015 2015 Q2
Q4 2013 78,264,000 07 Jan 2014 06 Feb 2014 10-K 14 Mar 2016 2015 FY
Q3 2013 21,085,283 01 Jul 2013 30 Sep 2013 10-Q 12 Nov 2014 2014 Q3
Q2 2013 21,080,414 01 Apr 2013 30 Jun 2013 10-Q 08 Aug 2014 2014 Q2

EKSO BIONICS HOLDINGS, INC. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 20,161,000 +6,294,000 +45% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2025 2024 FY
2023 13,867,000 +905,000 +7% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2025 2024 FY
2022 12,962,000 +693,000 +5.6% 01 Jan 2022 31 Dec 2022 10-K 04 Mar 2024 2023 FY
2021 12,269,000 +5,105,000 +71% 01 Jan 2021 31 Dec 2021 10-K 28 Mar 2023 2022 FY
2020 7,164,000 +2,370,000 +49% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2022 2021 FY
2019 4,794,000 -56,435,000 -92% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2021 2020 FY
2018 61,229,000 +25,620,000 +72% 01 Jan 2018 31 Dec 2018 10-K 27 Feb 2020 2019 FY
2017 35,609,000 +16,987,000 +91% 01 Jan 2017 31 Dec 2017 10-K 28 Feb 2019 2018 FY
2016 18,622,000 +4,013,000 +27% 01 Jan 2016 31 Dec 2016 10-K 13 Mar 2018 2017 FY
2015 14,609,000 +3,428,000 +31% 01 Jan 2015 31 Dec 2015 10-K 13 Mar 2018 2017 FY
2014 11,181,000 -9,796,000 -47% 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2017 2016 FY
2013 20,977,000 01 Jan 2013 31 Dec 2013 10-K 14 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.